Showing posts with label HEALTH MEDICAL PHARMA. Show all posts
Showing posts with label HEALTH MEDICAL PHARMA. Show all posts

Friday, 20 July 2018

Sunscreen can reduce skin cancer risk by 40% in youth: Study

Young adults who regularly use sunscreen reduce their risk of skin cancer by 40 per cent, a study has found.

According to the World Health Organization (WHO), between two and three million non-melanoma skin cancers and 1,32,000 melanoma skin cancers occur each year globally.
The global incidence of melanoma continues to increase, however, the main factors that predispose to the development of melanoma seem to be connected with recreational exposure to the sun and a history of sunburn. These factors lie within each individual’s own responsibility.

ALSO READ : CT scan may increase brain tumor risk

“The association of sun exposure and sunburn with melanoma risk, particularly in childhood, is well established and this study showed that regularly using sunscreen was protective against the harmful effects of sun exposure,” Xinhua news agency quoted lead researcher Anne Cust, Associate Professor at the University of Sydney in Australia, as saying.
Cust noted that it is still difficult to get people to regularly apply sunscreen, and that likelihood to do so depended on a number of factors.
“Regular users of sunscreen were more likely to be female, younger, of British or northern European ancestry, and have higher education levels, lighter skin pigmentation, and a strong history of blistering sunburn,” Cust said.
“People were less likely to use sunscreen if they were male, older, less educated, or had skin that was darker or more resistant to sunburn.”
For the study, the team analysed data of around 1,700 people aged between 18 to 40 years.
“This study confirms that sunscreen is an effective form of sun protection and reduces the risk of developing melanoma as a young adult,” Cust said.(Article Source : BS)

Thursday, 19 July 2018

CT scan may increase brain tumor risk

A new study shows that CT Scans, commonly used in medical imaging, may increase the risk of brain tumors.
Related image
The use of computed tomography (CT) scans has dramatically increased over the last two decades.
While CT scans have greatly improved diagnostic capabilities, they also deliver higher radiation doses than any other test. Therefore, radiation protection is a concern. Especially among children, who may receive higher radiation doses, are more open to radiation-related malignancies than adults. Children also have more time to show effects.
Leukemia and brain tumors are the most common malignancies caused by radioactivity among children and young adults. Researchers have therefore evaluated brain tumor and leukemia risks following exposure to radiation from CT scans in children.
From a nationwide group of 168,394 Dutch children who received one or more CT scans between the year 1979 and 2012, researchers found cancer incidents and vital status by recording linkage.
The study found that cancer incidents 1.5 times higher than expected. For all kinds of brain tumors combined and for malignant and nonmalignant brain tumors separately, dose-response relationships were seen with radiation dose to the brain.
Relative risks have increased to between two to four for highest dose category. The radiation doses to the bone marrow, where leukemia originates, were found to be low.
The study also shows that this pattern of excess cancer risk may be partially due to confounding by indication, as the incidence of brain tumor was higher in the cohort than in the general population.
CT scans are sometimes also used to identify conditions related to an increase tumor risk.
“Epidemiological studies of cancer risks from low doses of medical radiation are challenging, nevertheless, our careful evaluation of the data and evidence from other studies indicates that CT-related radiation exposure increases brain tumor risk. Careful justification of pediatric CT scans and dose optimization, as done in many hospitals, are essential to minimize risks.” said the study’s principal investigator, Michael Hauptmann.
The findings appeared in the journal, Journal of National Cancer Institute.(SOURCE : BS)

14th BRICS summit to review current global issues, reach key agreements

  At the   14th BRICS summit   which is to be hosted by China in a virtual mode on 23-24 June, the member nations will review the current gl...